Search research articles
Contact Us
Filters
Showing results (301-310 of 323) with videos related to
Page
of 33
Sort By:
Biomarker Research
|
July 25, 2023
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel
Jessica D Lang, Tuong Vi V Nguyen, Maren K Levin, et al.
Plos One
|
July 11, 2020
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Raffaella Soldi, Tithi Ghosh Halder, Alexis Weston, et al.
Journal of Personalized Medicine
|
December 23, 2022
Effect of a NICU to Home Physical Therapy Intervention on White Matter Trajectories, Motor Skills, and Problem-Solving Skills of Infants Born Very Preterm: A Case Series
Christiana Dodd Butera, Claire Rhee, Claire E Kelly, et al.
Pediatric Pulmonology
|
January 30, 2020
Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease
Judith A Voynow, Kimberley Fisher, Mary E Sunday, et al.
Rare Diseases (Austin, Tex.)
|
March 5, 2016
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
Pilar Ramos, Anthony N Karnezis, William P D Hendricks, et al.
Communications Biology
|
July 26, 2019
Canine osteosarcoma genome sequencing identifies recurrent mutations in <i>DMD</i> and the histone methyltransferase gene <i>SETD2</i>
Heather L Gardner, Karthigayini Sivaprakasam, Natalia Briones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines
Marc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics
|
September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Yemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2019
Identification of Recurrent Activating <i>HER2</i> Mutations in Primary Canine Pulmonary Adenocarcinoma
Gwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann, et al.
Med (New York, N.Y.)
|
July 5, 2021
Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer
Jonathan M Ghergurovich, Jessica D Lang, Maren K Levin, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 323) with videos related to
Sort By:
Page
of 33
Biomarker Research
|
July 25, 2023
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel
Jessica D Lang, Tuong Vi V Nguyen, Maren K Levin, et al.
Plos One
|
July 11, 2020
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Raffaella Soldi, Tithi Ghosh Halder, Alexis Weston, et al.
Journal of Personalized Medicine
|
December 23, 2022
Effect of a NICU to Home Physical Therapy Intervention on White Matter Trajectories, Motor Skills, and Problem-Solving Skills of Infants Born Very Preterm: A Case Series
Christiana Dodd Butera, Claire Rhee, Claire E Kelly, et al.
Pediatric Pulmonology
|
January 30, 2020
Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease
Judith A Voynow, Kimberley Fisher, Mary E Sunday, et al.
Rare Diseases (Austin, Tex.)
|
March 5, 2016
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
Pilar Ramos, Anthony N Karnezis, William P D Hendricks, et al.
Communications Biology
|
July 26, 2019
Canine osteosarcoma genome sequencing identifies recurrent mutations in <i>DMD</i> and the histone methyltransferase gene <i>SETD2</i>
Heather L Gardner, Karthigayini Sivaprakasam, Natalia Briones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines
Marc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics
|
September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Yemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2019
Identification of Recurrent Activating <i>HER2</i> Mutations in Primary Canine Pulmonary Adenocarcinoma
Gwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann, et al.
Med (New York, N.Y.)
|
July 5, 2021
Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer
Jonathan M Ghergurovich, Jessica D Lang, Maren K Levin, et al.
Page
of 33